Radio and PodcastRadio and PodcastLive Radio & Podcasts
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders artwork
Science & Medicine

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

Breast Cancer Update by Dr. Neil Love

Nov 20, 202558:36Science & Medicine

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic...

About This Episode

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders is an episode from Breast Cancer Update by Dr. Neil Love. Dr Erika Hamilton from Sarah Cannon Research In...

Podcast

This episode belongs to Breast Cancer Update.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Nov 20, 2025, 58:36 long, audio available.

Related Episodes

Continue listening to more episodes from Breast Cancer Update.

Questions About This Episode

What is HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders about?

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic breast cancer. CME information and select publications here .

Where can I listen to HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders?

You can listen to HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders from?

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders is an episode from Breast Cancer Update by Dr. Neil Love.

How long is this episode?

This episode is 58:36 long.

When was this episode published?

This episode was published on Nov 20, 2025.

Can I save HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from Breast Cancer Update?

Yes. This page shows related episodes from Breast Cancer Update when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders?

You can listen to HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders is from Breast Cancer Update by Dr. Neil Love.

What are the episode details?

Published Nov 20, 2025 and 58:36 long